July 14th, 2021– A couple months after landing $100 million in funding, Cellares grabs partner for its Cell Shuttle
July 14, 2021
Endpoints
Related News
-
September 22, 2025Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors
-
September 17, 2025
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control
-
May 30, 2025
Cellares and Mitsui Fudosan Announce the First IDMO Smart Factory for Commercial-Scale Cell Therapy Manufacturing in Japan
